Gilenya ‘prevents activation of key immune cells’
Gilenya ‘prevents activation of key immune cells’
In a recent study entitled Myeloid Cells As Target Of Gilenya Action In Multiple Sclerosis, a team of scientists investigated the impact of MS treatment Gilenya on the reactivity of myeloid cells, a key group that comprises several immune cells that are activated in MS patients and the underlying cause of the condition. The study was published in the journal Neurology...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/